Search for specific biomarkers of IFNβ bioactivity in patients with multiple sclerosis. - Test2 - elhamkhani - TriplyDB

Search for specific biomarkers of IFNβ bioactivity in patients with multiple sclerosis.

Search for specific biomarkers of IFNβ bioactivity in patients with multiple sclerosis.

http://www.wikidata.org/entity/Q34008878

about

A pharmacogenetic study implicates SLC9a9 in multiple sclerosis disease activity miR-942 decreases TRAIL-induced apoptosis through ISG12a downregulation and is regulated by AKT.Modular transcriptional repertoire analyses of adults with systemic lupus erythematosus reveal distinct type I and type II interferon signatures.Transcriptome analysis of peripheral blood mononuclear cells in human subjects following a 36 h fast provides evidence of effects on genes regulating inflammation, apoptosis and energy metabolism A robust type I interferon gene signature from blood RNA defines quantitative but not qualitative differences between three major IFNβ drugs in the treatment of multiple sclerosis.USP18 lack in microglia causes destructive interferonopathy of the mouse brain.Meta-Analysis of Differential Connectivity in Gene Co-Expression Networks in Multiple Sclerosis.Genome-wide analysis of DNA methylation, copy number variation, and gene expression in monozygotic twins discordant for primary biliary cirrhosis Multiple functions of USP18.Roles of the ubiquitin peptidase USP18 in multiple sclerosis and the response to interferon-β treatment.Editorial: the power of a modular approach to transcriptional analysis.Integrative analysis of Multiple Sclerosis using a systems biology approach.

P2860

Q28261215-0A8E8CA2-ED7C-4900-90D5-8D683E27D17F Q34104106-1A926263-41F6-4D5A-9EF4-423C32B4B1A5 Q34149941-C5319060-6268-421C-A95F-DE68C264E227 Q34252073-DF28D59C-EA1D-46DC-8D04-E0AA033B2C85 Q35568496-CCE2962E-6B44-40EC-8739-A9D71654E1F4 Q35762623-4918B346-54D4-46F5-9211-99BE4A211ADD Q37050779-4B078128-3CC2-47AC-9EFD-BA2158E2FC1F Q37683538-51E9950B-997D-4DA9-8C94-4A8ABAB4BF88 Q38997388-ED33FB6C-646B-4C25-A183-242F56E81F3F Q44563293-26EE99AC-9A95-4A9B-BCF2-AAC9D1272539 Q54233525-292543FC-9FD4-44F9-9405-A903C9DF1A47 Q54241747-4B1C062B-91AA-4202-A198-DC55F1D8DCB1

P2860

Search for specific biomarkers of IFNβ bioactivity in patients with multiple sclerosis.

http://www.wikidata.org/entity/Q34008878

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Search for specific biomarkers of IFNβ bioactivity in patients with multiple sclerosis.

@ast

Search for specific biomarkers of IFNβ bioactivity in patients with multiple sclerosis.

@en

Search for specific biomarkers of IFNβ bioactivity in patients with multiple sclerosis.

@nl

type

label

Search for specific biomarkers of IFNβ bioactivity in patients with multiple sclerosis.

@ast

Search for specific biomarkers of IFNβ bioactivity in patients with multiple sclerosis.

@en

Search for specific biomarkers of IFNβ bioactivity in patients with multiple sclerosis.

@nl

prefLabel

Search for specific biomarkers of IFNβ bioactivity in patients with multiple sclerosis.

@ast

Search for specific biomarkers of IFNβ bioactivity in patients with multiple sclerosis.

@en

Search for specific biomarkers of IFNβ bioactivity in patients with multiple sclerosis.

@nl

P1433

Q34008878-11DF9E8D-97A8-47D7-8F4D-4DDEBE2E52AB

P1476

Q34008878-307774E5-7DF5-4CF7-AF4A-FB65D6846D92

P2093

Q34008878-7D310AC8-5334-4F39-B95C-B924240D24F8

Q34008878-8376B992-88D4-4B53-857A-F713F4DCE04C

Q34008878-84B5295A-169C-491B-8924-C4BD8072F8EF

Q34008878-B8165CC7-A3C7-408F-A90F-4DAE9D950655

Q34008878-DCAB1247-35A6-4EDC-A998-47BFC46E6AFC

P2860

Q34008878-0AD93DEB-DBC8-4470-8185-0D332C4249F9

Q34008878-0F88EA35-B882-40AB-B4A9-9BFFB1CBAB0D

Q34008878-159B5D74-43EF-436B-9433-39F3BA15CAEC

Q34008878-165A5642-EEFE-4A52-B5E2-1F71A7CDEDB6

Q34008878-1D98D7A1-00A7-4096-AA9B-A9DDB0B0F481

Q34008878-23A2F42B-12B9-410A-8526-90729B73D296

Q34008878-38BBFD6F-7F53-4789-9FD0-CC3B6CE42B9A

Q34008878-3AFE096B-52FF-4ABC-969A-811468C26AC7

Q34008878-421847F3-2E49-41D2-8829-76CE459A3696

Q34008878-4401CD69-6391-4577-BF34-2B86A9B03C81

P304

Q34008878-6557EFB4-6B80-4CB5-A9A0-D2E8BB912DC2

P31

Q34008878-5A79449E-057A-4177-9518-9C1982E982A7

P356

Q34008878-76FEB6E6-26D6-4636-81AB-96A88E4D8953

P407

Q34008878-9ACF8DA5-578B-4C2C-843A-612B5484FA7B

P433

Q34008878-889763B1-FFEE-465C-9CF1-4D7CBC1E81F5

P478

Q34008878-26E67351-CC3B-42EB-8C65-ABD9C4AF58DD

P50

Q34008878-09290B60-6806-4443-8527-D2A87785A8BD

Q34008878-89996FF2-0A4D-41A7-BB2E-8BA7E38426F5

Q34008878-971AB895-5588-4001-8ED7-2E0EE37EA207

Q34008878-A34356A8-9A08-435D-B34C-A9DC1D953DA8

Q34008878-AD51BB90-139D-4AC1-9CCD-06A723462529

Q34008878-CF662562-F977-4158-A6D4-7172AC69DEFE

Q34008878-EC449799-3B24-4B58-B672-BCD8807F2FAC

P577

Q34008878-7DE85850-5A0C-47B7-91B2-73821F33B37D

P5875

Q34008878-6FA904EE-B2C0-43CB-9875-12771881E8CE

P698

Q34008878-504E94BA-2E3B-4938-B18C-E786E34059D3

P921

Q34008878-90699E95-7A38-4368-8C42-7AE55F7BE2A4

Q34008878-B9CCC2CA-A69C-418B-A286-0CE202FDEFF2

P932

Q34008878-AEB4381F-35BD-48DE-B70E-63B2C00EE4C0

P356

JOURNAL.PONE.0023634

P1433

P1476

Search for specific biomarkers of IFNβ bioactivity in patients with multiple sclerosis

@en

P2093

Florian Deisenhammer

http://www.w3.org/2001/XMLSchema#string

Lara Nonell

http://www.w3.org/2001/XMLSchema#string

Manuel Comabella

http://www.w3.org/2001/XMLSchema#string

Mari Carmen Ruiz de Villa

http://www.w3.org/2001/XMLSchema#string

Marta F Bustamante

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacogenomics of interferon-beta therapy in multiple sclerosis: baseline IFN signature determines pharmacological differences between patients

G1P3, an interferon inducible gene 6-16, is expressed in gastric cancers and inhibits mitochondrial-mediated apoptosis in gastric cancer cell line TMK-1 cell

Mitochondrial localization and pro-apoptotic effects of the interferon-inducible protein ISG12a

UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity

TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes

Protein ISGylation modulates the JAK-STAT signaling pathway

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

UBP43 (USP18) specifically removes ISG15 from conjugated proteins.

High-throughput immunoblotting. Ubiquitiin-like protein ISG15 modifies key regulators of signal transduction.

Cutting edge: CD43 functions as a T cell counterreceptor for the macrophage adhesion receptor sialoadhesin (Siglec-1)

P304

e23634

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0023634

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Ramil Nurtdinov

Francisco Pérez-Miralles

Xavier Montalban

Nicolás Fissolo

P577

2011-08-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51614466

http://www.w3.org/2001/XMLSchema#string

P698

21886806

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis

P932

3160307

http://www.w3.org/2001/XMLSchema#string